The contract signed with Sandoz, a generic company within the Novartis company, is worth 21.5 million.
Uso Racional is expected to make 12 million euros from sales this year. The company has a small sales team, Pliva officials said.
ZAGREB, Feb 15 (Hina) - A day after it announced that by selling itsresearch institute GlaxoSmithKleinu, thus leaving the proprietarybusiness and becoming exclusively a global generic company, theCroatian pharmaceutical company Pliva
announced on Wednesday it boughtthe Spanish generic company Uso Racional.
ZAGREB, Feb 15 (Hina) - A day after it announced that by selling
its research institute GlaxoSmithKleinu, thus leaving the proprietary business
and becoming exclusively a global generic company, the Croatian pharmaceutical
company Pliva announced on Wednesday it bought the Spanish generic company Uso
Racional.